Aviwell SAS has successfully raised €11 million in Series A funding to scale its AI-driven microbiome discovery platform and develop sustainable animal nutrition solutions, primarily in poultry and aquaculture.

Target Information

Aviwell SAS, a Toulouse-based deep-tech company, specializes in animal nutrition solutions that integrate advanced microbiome research and artificial intelligence. The company has successfully completed a €11 million Series A funding round, attracting key investors including Blue Revolution Fund (BRF), Blast.Club, and SWEN Capital Partners. This financing will enable Aviwell to accelerate its growth trajectory as it enhances its AI-driven microbiome discovery platform and develops nature-based solutions tailored for the agri-food sector, with a focus on poultry and aquaculture.

Founded on decades of research led by co-Founder Prof. Remy BURCELIN, Aviwell has created Aneto™, a pioneering AI-powered microbiome discovery platform. Aneto™ is designed to uncover specific molecular mechanisms that enable the selection of tailored bacterial communities, aimed at improving various aspects of animal health and performance. The innovative platform allows for a streamlined discovery process, reducing the time and costs associated with research and development while facilitating quicker market entry.

Industry Overview

The global demand for animal protein is experiencing significant growth, driven by increasing populations and changing dietary preferences. This surge presents both opportunities and challenges within the animal nutrition industry, particularly in E